1. Home
  2. NMRA vs TG Comparison

NMRA vs TG Comparison

Compare NMRA & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neumora Therapeutics Inc.

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$0.67

Market Cap

302.0M

Sector

N/A

ML Signal

HOLD

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.07

Market Cap

239.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMRA
TG
Founded
2019
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
302.0M
239.6M
IPO Year
2023
1994

Fundamental Metrics

Financial Performance
Metric
NMRA
TG
Price
$0.67
$7.07
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $7.50
N/A
AVG Volume (30 Days)
★ 1.2M
136.5K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
5.23
★ 151.06
EPS
N/A
★ 0.34
Revenue
N/A
★ $800,821,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$20.74
Revenue Growth
N/A
★ 8.29
52 Week Low
$0.68
$6.25
52 Week High
$3.65
$10.53

Technical Indicators

Market Signals
Indicator
NMRA
TG
Relative Strength Index (RSI) 21.97 42.10
Support Level N/A $6.42
Resistance Level $1.74 $8.10
Average True Range (ATR) 0.10 0.24
MACD -0.02 0.00
Stochastic Oscillator 6.33 46.18

Price Performance

Historical Comparison
NMRA
TG

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

Share on Social Networks: